Researchers tested a new radiotheranostic pair that targets CAIX in metastatic kidney cancer, showing strong tumor uptake, early responses, and limited major organ toxicity.
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
